Page 3 - Weight Management Program News Today

After spending $138 million on weight loss medication last year, the NC treasurer's office said the state can't afford specific drugs like Wegovy.

Amgen is testing a monthly injection that works differently and appears to help patients maintain their weight loss even after they stop taking it.

Amgen is testing a monthly injection that works differently and appears to help patients maintain their weight loss even after they stop taking it.

When someone has obesity, losing even 5% of their body weight can make a major difference in their health -- especially if they can keep from regaining it.

Obesity care under a health care provider’s supervision, whether through nutrition counseling, medication, meal replacement or bariatric surgery, can help peo

Approximately 80% of Veterans are overweight or obese, according to the Department of Veterans Affairs. Donald Logan was one of them. Following a hospitalization for diabetes in July 2023, the Army Ve...

Last year, 3,316 semaglutide overdoses were reported by 55 poison control centers in the U.S. Compounded versions, which can contain semaglutide salts, are likely behind most of the overdoses.

IRVINE, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences ® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that bariatric surgical fellows from

Doctors hope FDA approval of a pill for postpartum depression called Zuranolone (under the brand name Zurzuvae) could raise awareness and increase treatment options for this debilitating condition.

The U.S. Food and Drug Administration approved Zepbound (tirzepatide) injection for chronic weight management in adults with obesity. Tirzepatide, the active ingredient in Zepbound, is already approved under the trade name Mounjaro to be used along with diet and exercise to help improve blood sugar in adults with type 2 diabetes mellitus.